Evidence map›Paper›PMID 40245863›Full record

ArticleAmerican journal of human genetics2025

First steps toward building natural history of diseases computationally: Lessons learned from the Noonan syndrome use case.

Tudor Groza, Warittha Rayabsri, Dylan Gration, Harshini Hariram, Saumya Shekhar Jamuar, Gareth Baynam

Abstract read
In one paragraph

Article in American journal of human genetics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Tudor GrozaRare Care Centre, Perth Children's Hospital, Nedlands, WA 6009, Australia; Bioinformatics Institute, Agency for Science, Technology and Research (A(∗)STAR), 30 Biopolis Street #07-01 Matrix, Singapore 138671, Singapore; SingHealth Duke-NUS Institute of Precision Medicine, 5 Hospital Drive Level 9, Singapore 169609, Singapore; School of Electrical Engineering, Computing and Mathematical Sciences, Curtin University, Kent Street, Bentley, WA 6102, Australia. Electronic address: tudor.groza@health.wa.gov.au.
Warittha RayabsriWestern Australian Register of Developmental Anomalies, King Edward Memorial Hospital, 374 Bagot Road, Subiaco, WA 6008, Australia.
Dylan GrationWestern Australian Register of Developmental Anomalies, King Edward Memorial Hospital, 374 Bagot Road, Subiaco, WA 6008, Australia.
Harshini HariramMedical Student, Division of Medical Education, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester M13 9PL, UK.
Saumya Shekhar JamuarSingHealth Duke-NUS Institute of Precision Medicine, 5 Hospital Drive Level 9, Singapore 169609, Singapore; Genetics Service, Department of Paediatrics, KK Women's and Children's Hospital, 100 Bukit Timah Road, Singapore 229899, Singapore; SingHealth Duke-NUS Genomic Medicine Centre, 100 Bukit Timah Road, Singapore 229899, Singapore.
Gareth BaynamRare Care Centre, Perth Children's Hospital, Nedlands, WA 6009, Australia; Western Australian Register of Developmental Anomalies, King Edward Memorial Hospital, 374 Bagot Road, Subiaco, WA 6008, Australia; Faculty of Health and Medical Sciences, University of Western Australia, 35 Stirling Highway, Crawley, WA 6009, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rare diseases (RDs) are conditions affecting fewer than 1 in 2,000 people, with over 7,000 identified, primarily genetic in nature, and more than half impacting children. Although each RD affects a small population, collectively, between 3.5% and 5.9% of the global population, or 262.9-446.2 million people, live with an RD. Most RDs lack established treatment protocols, highlighting the need for proper care pathways addressing prognosis, diagnosis, and management. Advances in generative AI and large language models (LLMs) offer new opportunities to document the temporal progression of phenotypic features, addressing gaps in current knowledge bases. This study proposes an LLM-based framework to capture the natural history of diseases, specifically focusing on Noonan syndrome. The framework aims to document phenotypic trajectories, validate against RD knowledge bases, and integrate insights into care coordination using electronic health record (EHR) data from the Undiagnosed Diseases Program Singapore.

Indexed as

Noonan SyndromeRare DiseasesChildElectronic Health RecordsHumansKnowledge BasesPhenotypeSingaporegenerative AIHuman Phenotype OntologyLarge Language Modelsnatural history of diseaseNoonan syndromerare diseases

Identifiers

PMID40245863
PMCPMC12120186

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.